6th Annual TIL Therapies Summit
Evvnt Promotion / evvnt
22.10.2024 - 24.10.2024 Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, Massachusetts, USA
Time: 9:00 am to 5:30 pm
Kongressthemen
Following the watershed approval of Iovances' Lifileucel, all eyes are now on TIL therapies as the up-and-coming major therapeutic avenue for solid tumor treatment.
The 6th Annual TIL Therapies Summit returns to Boston as the only meeting putting the entire spotlight on TIL drug development, giving you an unmissable opportunity to capitalize on the wave of excitement into this field, as the blockbuster potential of harnessing TILs is now realized with the regulatory seal of approval.
Following the watershed approval of Iovances' Lifileucel, all eyes are now on TIL therapies as the up-and-coming major therapeutic avenue for solid tumor treatment.
The 6th Annual TIL Therapies Summit returns to Boston as the only meeting putting the entire spotlight on TIL drug development, giving you an unmissable opportunity to capitalize on the wave of excitement into this field, as the blockbuster potential of harnessing TILs is now realized with the regulatory seal of approval.
Wissenschaftliche Fach-Gesellschaft
Hanson Wade
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/2439241-3?pid=4832
Speakers: Andrea Aran Garriga, Postdoctoral Researcher, Hospital Clinic Barcelona, Andrew Weinberg, President and Chief Scientific Officer, AgonOx and more.
Brochure: https://go.evvnt.com/2439241-3?pid=4832
Speakers: Andrea Aran Garriga, Postdoctoral Researcher, Hospital Clinic Barcelona, Andrew Weinberg, President and Chief Scientific Officer, AgonOx and more.
Anfragen und Anmeldung:
https://go.evvnt.com/2439241-2?pid=4832
Frau Lara Chick
Gesundheitsversorgung, Public Health
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
